SCHEMBL26547633

SCHEMBL26547633

CC(C)Nc1ccc(-n2ccnc2)cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PCSK9 Q8NBP7 1/20 0.54
PORCN Q9H237 2/20 0.48
CYP3A4 P08684 6/20 0.46
CYP2A6 P11509 1/20 0.46
CYP2D6 P10635 3/20 0.46
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
ENPP2 Q13822 1/20 0.44
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
NOTUM Q6P988 1/20 0.44
ADH5 P11766 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRB3 P28472 1/20 0.43
GABRA5 P31644 1/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
HTT P42858 2/20 0.42
CYP11B1 P15538 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24782873 0.79 LMNA (0.55) PORCNCYP3A4CYP2D6LMNAMAPT
SCHEMBL26550130 0.79 PCSK9 (0.57) PCSK9CYP3A4CYP2A6CYP2D6LMNA
SCHEMBL26548539 0.79 HRH4 (0.47) CYP3A4CYP2A6CYP2D6LMNAMAPT
SCHEMBL20085576 0.76 CYP3A4 (0.54) PCSK9CYP3A4CYP2A6CYP2D6LMNA
SCHEMBL19296052 0.74 CYP3A4 (0.59) CYP3A4CYP2A6CYP2D6LMNAMAPT
SCHEMBL13034788 0.73 TSHR (0.51) NPC1TSHRHSD17B10
SCHEMBL26548536 0.73 PCSK9 (0.54) PCSK9PORCNCYP3A4CYP2A6CYP2D6
SCHEMBL26550116 0.71 CDK6 (0.46) PCSK9CYP3A4MAPTCYP1A2CYP2C9
SCHEMBL22241708 0.71 PCSK9 (1.00) PCSK9
SCHEMBL1839540 0.70 LMNA (0.61) CYP3A4CYP2A6CYP2D6LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed